Understanding Exercise-induced Protection in Heart Failure with Reduced Ejection Fraction and Heart Failure with Preserved Ejection Fraction: Molecular Mechanisms and New Therapeutic Opportunities. [PDF]
Liu RP, Watson LE, McMullen JR.
europepmc +1 more source
HDACs as a therapeutic target in HFpEF [PDF]
openaire +2 more sources
Cardioprotective hormone relaxin‐2 showed relevant effects on rat skeletal muscle by altering proteins linked to muscle function, regeneration, differentiation, mitochondrial function, glucose metabolism, and structural integrity and organization. Specifically, relaxin‐2 reduced the expression of 95 proteins, increased 32, and elicited unique proteins ...
Xocas Vázquez‐Abuín +11 more
wiley +1 more source
Perimenopause as a potential window of cardiometabolic remodeling in heart failure with preserved ejection fraction: a missed opportunity for prevention. [PDF]
Adejumo FA +3 more
europepmc +1 more source
Short-Chain Fatty Acids in Heart Failure with Preserved Ejection Fraction: Pathophysiological Roles and Therapeutic Potential. [PDF]
Lyu Y +6 more
europepmc +1 more source
Microglia Drive Hypothalamic Inflammation in HFpEF Through Extracellular Vesicles Released From the Heart. [PDF]
Ardehali H.
europepmc +1 more source
Automated assessment of echocardiograms to aid diagnosis of heart failure with preserved ejection fraction. [PDF]
Venema CS +17 more
europepmc +1 more source
Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation. [PDF]
Jaeschke L +34 more
europepmc +1 more source

